91147-46-5: Brimonidine EP Impurity H
Brimonidine EP Impurity H ( CAS No: 91147-46-5 ) or 5-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine is the associate impurity of Brimonidine. Brimonidine is employed to treat the symptoms of Elevated Intraocular Pressure and Ocular Redness.
Additional information on CAS 91147-46-5
Catalogue No.
VE006452
CAS No.
91147-46-5
Molecular Formula
C11H10ClN5
Molecular Weight
247.68
Parent drug
Brimonidine
IUPAC Name
5-Chloro-N-(4, 5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine
Synonyms
N/A
References
“Sci-Hub, Brimonidine Tartrate, 10.1016/S0161-6420(97)30349-2.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.1016/S0161-6420(97)30349-2.
Status
In-stock
Other products related to brimonidine
Name of Impurity | Catalogue No. | |
---|---|---|
Brimonidine 2, 3-Dione Impurity | VE007423 | View CAS 182627-95-8 |
Brimonidine Acrylate | VE007429 | View |
Brimonidine Carbamothioate Impurity | VE007424 | View CAS 842138-75-4 |
Brimonidine Dimer Impurity | VE007428 | View |
Brimonidine EP Impurity A | VL1910004 | View CAS 91147-43-2 |
Brimonidine EP Impurity B | VL1910003 | View CAS 50358-63-9 |
Brimonidine EP Impurity C | VL1910002 | View CAS 6298-37-9 |
Brimonidine EP Impurity D | VL1910005 | View CAS 842138-74-3 |
Brimonidine EP Impurity E | VL1910001 | View CAS 168329-48-4 |
Brimonidine EP Impurity F | VE007425 | View CAS 151110-15-5 |
Brimonidine EP Impurity G | VE006448 | View CAS 1216379-05-3 |
Brimonidine Inhouse Impurity I | VE007431 | View CAS 134892-46-9 |
Brimonidine Nitroso Impurity | VE0010619 | View |
Brimonidine Related Impurity 4 | VE007430 | View CAS 182628-02-0 |
Brimonidine Tartrate Impurity 3 | VE007426 | View CAS 1217439-06-9 |
N-(2-Aminoethyl)-N'-(5-bromo-6-quinoxalinyl)thiourea | VE008657 | View CAS 134892-47-0 |
6-Isothiocyanatoquinoxaline | VE007427 | View CAS 135306-56-8 |